Home > Quotes > VICL

Vical Incorporated Common Stock Quote & Summary Data

Get VICL Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading VICL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Vical Incorporated Common Stock Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 0.399 $ 1.55
Low $ 0.375 $ 0.2808

The current last sale of $0.399 is 42.09% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We research and develop biopharmaceutical products, including those based on our patented DNA delivery technologies, for the prevention and treatment of serious or life-threatening diseases. We currently have four active, independent or partnered, development programs in the area of infectious disease comprised of: ยท An ongoing Phase 3 clinical trial of ASP0113 for prevention of cytomegalovirus, or CMV, reactivation in hematopoietic stem cell transplant recipients and an ongoing Phase 2 clinical trial of ASP0113 for prevention of CMV infection in kidney transplant recipients, both in collaboration with Astellas Pharma Inc., or Astellas. Astellas expects enrollment in the Phase 3 clinical trial to be completed during the third quarter of 2016.  ... More ...  

Risk Grade

Where does VICL fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?